pilsicainide has been researched along with Tachycardia in 4 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
Tachycardia: Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pilsicainide is a class Ic antiarrhythmic agent used for the treatment of supraventricular and ventricular tachycardia." | 4.86 | Pilsicainide. ( Plosker, GL, 2010) |
| "Syncope was abolished after successful radiofrequency catheter ablation of the AFL." | 1.31 | Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs. ( Azegami, K; Hiejima, K; Hirao, K; Horikawa, T; Kawabata, M; Motokawa, K; Suzuki, F; Suzuki, K, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Plosker, GL | 1 |
| Komatsu, T | 1 |
| Sato, Y | 1 |
| Tachibana, H | 1 |
| Nakamura, M | 1 |
| Horiuchi, D | 1 |
| Okumura, K | 1 |
| Kawabata, M | 1 |
| Hirao, K | 1 |
| Horikawa, T | 1 |
| Suzuki, K | 1 |
| Motokawa, K | 1 |
| Suzuki, F | 1 |
| Azegami, K | 1 |
| Hiejima, K | 1 |
| Nakazato, Y | 1 |
| Nakata, Y | 1 |
1 review available for pilsicainide and Tachycardia
| Article | Year |
|---|---|
Pilsicainide.
Topics: Anti-Arrhythmia Agents; Humans; Lidocaine; Tachycardia | 2010 |
1 trial available for pilsicainide and Tachycardia
| Article | Year |
|---|---|
Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy.
Topics: Adult; Age Factors; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Disease-F | 2006 |
2 other studies available for pilsicainide and Tachycardia
| Article | Year |
|---|---|
Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Catheter Ablation; Electrocardiography; Electrophysio | 2001 |
Images in cardiology: Successful treatment of atrial tachycardia-induced cardiomyopathy with pilsicainide.
Topics: Adolescent; Anti-Arrhythmia Agents; Cardiomegaly; Female; Humans; Lidocaine; Radiography; Stroke Vol | 2001 |